Sarepta Patient Deaths Investigation - Search News

Order byBest matchMost fresh

News

FDA asks Sarepta to stop shipping gene therapy

Southwest Journal · 2d

Breaking: Second Patient Death Prompts FDA Investigation of Sarepta’s Elevidys Gene Therapy

Second patient death from liver failure after Sarepta's Elevidys gene therapy triggers FDA investigation. Stock crashes 41% as company halts non-ambulatory patient treatments.

Continue reading

Sarepta tells FDA it won’t halt shipments despite patient deaths

· 2d · on MSN

Sarepta shares fall 37% as FDA questions future of key gene therapy

2d

Drugmaker Refuses F.D.A. Request to Pull Treatment Linked to Patient Deaths

The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Elevidys, after three patients died from ...

NBC4 WCMH-TV on MSN1d

Sarepta Therapeutics lays off 500 employees amid FDA investigation, including 80 in Columbus

Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location.

Sarepta Tags DMD Gene Therapy Elevidys With Black Box Warning, Axes 500 Staff

Following the death of two teenage patients with Duchenne muscular dystrophy following Elevidys treatment, Sarepta ...

GEN - Genetic Engineering and Biotechnology News3d

Sarepta Axes 500, 36% of Workforce, in Restructuring after DMD Patient Deaths

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results